GFOO logo

Genufood Energy Enzymes Corp. (GFOO)

Nur zu Informationszwecken. Keine Finanzberatung. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

GFOO steht fuer Genufood Energy Enzymes Corp., ein Financial Services-Unternehmen mit einem Kurs von $ (Marktkapitalisierung 0). Bewertet mit 44/100 (vorsichtig) bei Wachstumspotenzial, finanzieller Gesundheit und Momentum.

Zuletzt analysiert: 17. März 2026
44/100 KI-Bewertung

Genufood Energy Enzymes Corp. (GFOO) Finanzdienstleistungsprofil

CEODavid Tang
Mitarbeiter1
HauptsitzArcadia, US
IPO-Jahr2013

Genufood Energy Enzymes Corp., operating within the Financial Services sector as a shell company, lacks significant current operations after previously engaging in the manufacturing and distribution of enzyme products. The company's minimal market capitalization and high beta reflect its speculative nature and limited activity in the market.

Datenherkunft | Finanzdaten Quantitative Analyse NASDAQ Analyse: 17. März 2026

Investmentthese

Investing in Genufood Energy Enzymes Corp. (GFOO) presents a highly speculative opportunity. The company's current lack of significant operations and minimal market capitalization of $0.00B indicate substantial risk. The high beta of 5.09 suggests extreme volatility relative to the market. Potential value drivers hinge on the possibility of a reverse merger, acquisition, or strategic shift into a new business. However, without concrete plans or active operations, the investment thesis relies heavily on speculation. Investors should carefully consider the risks associated with shell companies and the lack of financial performance data.

Basierend auf FMP-Finanzdaten und quantitativer Analyse

Wichtige Highlights

  • Market capitalization of $0.00B indicates the company's small size and limited investor confidence.
  • A P/E ratio of -0.13 reflects negative earnings and the company's lack of profitability.
  • Beta of 5.09 suggests high volatility compared to the overall market.
  • Dividend yield of None indicates that the company does not currently distribute profits to shareholders.
  • The company's status as a shell company implies a high degree of uncertainty and risk.

Wettbewerber & Vergleichsunternehmen

Staerken

  • Existing corporate structure
  • Publicly listed status
  • Potential for reverse merger
  • Low market capitalization

Schwaechen

  • Lack of active operations
  • Minimal assets
  • Negative earnings
  • High beta

Katalysatoren

  • Upcoming: Potential announcement of a reverse merger agreement.
  • Upcoming: Possible acquisition offer from another company.
  • Upcoming: Strategic pivot into a new business sector.
  • Ongoing: Exploration of potential business opportunities.
  • Ongoing: Efforts to raise capital for future ventures.

Risiken

  • Potential: Failure to find a suitable merger or acquisition target.
  • Potential: Inability to raise capital to fund new ventures.
  • Ongoing: Limited liquidity and trading volume.
  • Ongoing: High volatility and speculative nature of the stock.
  • Potential: Delisting from the OTC market.

Wachstumschancen

  • Reverse Merger: A potential growth opportunity lies in a reverse merger, where a private company merges with GFOO to gain a public listing without undergoing the traditional IPO process. This could inject new assets, operations, and management into GFOO, revitalizing the company and potentially increasing its market value. The timeline for such a transaction is highly uncertain, dependent on finding a suitable private company and negotiating favorable terms. Market size is dependent on the valuation of the acquired company.
  • Acquisition Target: GFOO could become an acquisition target for another company seeking a publicly traded shell. This would provide existing shareholders with a return on their investment, although the terms of the acquisition would determine the ultimate value. The timeline for an acquisition is unpredictable, influenced by market conditions and the strategic interests of potential acquirers. The market size is dependent on the acquisition price.
  • Strategic Pivot: GFOO could strategically pivot into a new business sector, leveraging its existing corporate structure and public listing. This would require a significant investment of capital and resources, as well as a comprehensive business plan. The timeline for a strategic pivot is dependent on the company's ability to identify and execute a viable business strategy. Market size is dependent on the chosen sector.
  • Capital Raise: GFOO could attempt to raise capital through equity or debt offerings to fund new ventures or acquisitions. This would require a compelling business plan and investor confidence in the company's management team. The timeline for a capital raise is dependent on market conditions and investor appetite. Market size is dependent on the amount of capital raised.
  • Asset Acquisition: GFOO could acquire assets from other companies, such as intellectual property, equipment, or real estate. This would provide the company with tangible assets and potential revenue streams. The timeline for an asset acquisition is dependent on finding suitable assets and negotiating favorable terms. Market size is dependent on the value of the acquired assets.

Chancen

  • Reverse merger with a private company
  • Acquisition by another company
  • Strategic pivot into a new business
  • Capital raise to fund new ventures

Risiken

  • Failure to find a suitable merger or acquisition target
  • Inability to raise capital
  • Economic downturn
  • Increased regulatory scrutiny

Wettbewerbsvorteile

  • As a shell company, GFOO's primary advantage is its existing corporate structure and public listing.
  • This can provide a faster and less expensive route to market for private companies seeking to go public.
  • However, GFOO lacks a traditional economic moat due to its lack of active operations.

Ueber GFOO

Genufood Energy Enzymes Corp. was incorporated in 2010 and is based in Arcadia, California. The company's historical business involved the manufacturing, exporting, and distributing of enzyme products intended as supplements for both human and animal consumption. However, as of 2026, Genufood Energy Enzymes Corp. does not have significant ongoing operations. This transition from an active enzyme product business to a shell company represents a significant shift in the company's trajectory. The company's current state suggests a potential restructuring, acquisition target, or strategic pivot, although no specific plans have been publicly disclosed. The lack of current operations and minimal market capitalization reflect the speculative nature of the company's stock. The company's future direction remains uncertain, contingent on potential new ventures or strategic realignments.

Was das Unternehmen tut

  • Currently, Genufood Energy Enzymes Corp. does not have significant operations.
  • Previously, the company manufactured enzyme products.
  • The company exported enzyme products.
  • They distributed enzyme products.
  • The enzyme products were intended as supplements for human consumption.
  • The enzyme products were also intended as supplements for animal consumption.

Geschaeftsmodell

  • Historically, the company generated revenue through the sale of enzyme products.
  • The company's business model involved manufacturing, exporting, and distributing these products.
  • Currently, the company does not have an active business model.

Branchenkontext

Genufood Energy Enzymes Corp. operates within the shell company industry, a segment of the financial services sector characterized by companies with no active business operations or significant assets. These companies are often formed for the purpose of facilitating mergers, acquisitions, or reverse takeovers. The shell company industry is highly speculative, with potential for high returns but also significant risks. The competitive landscape is diverse, ranging from newly formed entities to established companies seeking to restructure or enter new markets. Genufood Energy Enzymes Corp.'s position as a shell company reflects its current lack of operational activity and dependence on future strategic developments.

Wichtige Kunden

  • Historically, the company's customers included individuals seeking enzyme supplements.
  • The company also served customers in the animal feed industry.
  • Currently, the company does not have active customers.
KI-Zuversicht: 69% Aktualisiert: 17. März 2026

Finanzdaten

Chart & Info

Genufood Energy Enzymes Corp. (GFOO) Aktienkurs: Price data unavailable

Aktuelle Nachrichten

Analystenkonsens

Konsens-Bewertung

Aggregierte Kauf-/Halten-/Verkauf-Empfehlungen von Benzinga, Yahoo Finance und Finnhub fuer GFOO.

Kursziele

Wall-Street-Kurszielanalyse fuer GFOO.

MoonshotScore

44/100

Was bedeutet diese Bewertung?

Der MoonshotScore bewertet das Wachstumspotenzial von GFOO auf einer Skala von 0-100 ueber mehrere Faktoren wie Innovation, Marktdisruption, finanzielle Gesundheit und Momentum.

Fuehrung: David Tang

Unknown

David Tang is the managing member of Genufood Energy Enzymes Corp. Details regarding his prior experience and educational background are not available. His role involves overseeing the limited operations of the company, which currently functions as a shell corporation. The company employs only one individual, indicating a very lean operational structure.

Erfolgsbilanz: Given the company's current state as a shell corporation without significant operations, it is difficult to assess David Tang's track record in terms of driving revenue growth or achieving strategic milestones. His primary responsibility appears to be maintaining the company's corporate structure and exploring potential future opportunities.

GFOO OTC-Marktinformationen

The OTC Other tier represents the lowest tier of the OTC market, encompassing stocks that may not meet the minimum financial standards or disclosure requirements of higher tiers like OTCQX or OTCQB. Companies in this tier often have limited financial information available, and may not be current in their reporting obligations. Investing in OTC Other stocks carries a higher degree of risk due to the potential for fraud, manipulation, and lack of transparency. These securities are often considered highly speculative.

  • OTC-Stufe: OTC Other
  • Offenlegungsstatus: Unknown
Liquiditaet: Liquidity for GFOO is likely very limited given its status as a shell company and its presence on the OTC Other tier. Bid-ask spreads are expected to be wide, and trading volume may be minimal or nonexistent on some days. This lack of liquidity can make it difficult to buy or sell shares at desired prices, potentially leading to significant losses.
OTC-Risikofaktoren:
  • Limited or no financial disclosure
  • High potential for fraud or manipulation
  • Lack of liquidity
  • Speculative nature of the company
  • Potential for delisting or suspension of trading
Sorgfaltspruefung-Checkliste:
  • Verify the company's registration and legal status
  • Review any available financial statements
  • Assess the company's management team and their experience
  • Research the company's history and any past legal issues
  • Understand the risks associated with investing in OTC Other stocks
  • Monitor trading volume and bid-ask spreads
  • Consult with a financial advisor
Legitimitaetssignale:
  • Verify the company's registration with the SEC or other regulatory bodies.
  • Check for any history of regulatory violations or legal issues.
  • Assess the experience and qualifications of the company's management team.
  • Look for any independent audits or certifications.
  • Monitor news and press releases for any red flags.

Was Anleger ueber Genufood Energy Enzymes Corp. (GFOO) wissen wollen

What are the key factors to evaluate for GFOO?

Genufood Energy Enzymes Corp. (GFOO) currently holds an AI score of 44/100, indicating low score. Key strength: Existing corporate structure. Primary risk to monitor: Potential: Failure to find a suitable merger or acquisition target.. This is not financial advice.

How frequently does GFOO data refresh on this page?

GFOO prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.

What has driven GFOO's recent stock price performance?

Recent price movement in Genufood Energy Enzymes Corp. (GFOO) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Existing corporate structure. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.

Should investors consider GFOO overvalued or undervalued right now?

Determining whether Genufood Energy Enzymes Corp. (GFOO) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.

What research should beginners do before buying GFOO?

Before investing in Genufood Energy Enzymes Corp. (GFOO), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).

Why might investors consider adding GFOO to a portfolio?

Potential reasons to consider Genufood Energy Enzymes Corp. (GFOO) depend on individual investment goals and risk tolerance. A key strength identified by analysis: Existing corporate structure. Additionally: Publicly listed status. Always weigh potential rewards against risks and diversify across holdings. This is not financial advice.

Can I buy fractional shares of GFOO?

Yes, most major brokerages offer fractional shares of Genufood Energy Enzymes Corp. (GFOO) with no minimum purchase requirement. This means you can invest any dollar amount regardless of the share price. Check your brokerage platform for specific terms, fees, and fractional share availability.

How can I track GFOO's earnings and financial reports?

Genufood Energy Enzymes Corp. (GFOO) reports quarterly earnings approximately 4-6 weeks after each fiscal quarter ends. You can track earnings dates, revenue and EPS estimates, and actual results on this page's Financials tab. Earnings surprises (beats or misses) often cause significant short-term price moves. Setting up alerts through your brokerage for GFOO earnings announcements is recommended.

Haftungsausschluss: Dieser Inhalt dient ausschliesslich zu Informationszwecken und stellt keine Anlageberatung dar. Fuehren Sie immer Ihre eigene Recherche durch und konsultieren Sie einen Finanzberater.

Offizielle Ressourcen

Analyse aktualisiert am KI-Bewertung taeglich aktualisiert
Datenquellen & Methodik
Marktdaten bereitgestellt von Financial Modeling Prep & Yahoo Finance. KI-Analyse durch proprietaere Algorithmen von Stock Expert AI. Technische Indikatoren nach branchenueblichen Berechnungsstandards. Zuletzt aktualisiert: .

Daten dienen ausschliesslich zu Informationszwecken.

Analysehinweise
  • Information is based on publicly available sources and may be limited due to the company's status as a shell corporation.
  • The analysis is subject to change based on new information or events.
Datenquellen

Popular Stocks